Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2014 Jan 23;9(1):e86136.
doi: 10.1371/journal.pone.0086136. eCollection 2014.

Age-dependent prevalence of nasopharyngeal carriage of streptococcus pneumoniae before conjugate vaccine introduction: a prediction model based on a meta-analysis

Affiliations
Meta-Analysis

Age-dependent prevalence of nasopharyngeal carriage of streptococcus pneumoniae before conjugate vaccine introduction: a prediction model based on a meta-analysis

Olivier Le Polain de Waroux et al. PLoS One. .

Abstract

Introduction: Data on the prevalence of nasopharyngeal carriage of S.pneumoniae in all age groups are important to help predict the impact of introducing pneumococcal conjugate vaccines (PCV) into routine infant immunization, given the important indirect effect of the vaccine. Yet most carriage studies are limited to children under five years of age. We here explore the association between carriage prevalence and serotype distribution in children aged ≥5 years and in adults compared to children.

Methods: We conducted a systematic review of studies providing carriage estimates across age groups in healthy populations not previously exposed to PCV, using MEDLINE and Embase. We used Bayesian linear meta-regression models to predict the overall carriage prevalence as well as the prevalence and distribution of vaccine and nonvaccine type (VT and NVT) serotypes in older age groups as a function of that in <5 y olds.

Results: Twenty-nine studies compromising of 20,391 individuals were included in the analysis. In all studies nasopharyngeal carriage decreased with increasing age. We found a strong positive linear association between the carriage prevalence in pre-school childen (<5 y) and both that in school aged children (5-17 y olds) and in adults. The proportion of VT serotypes isolated from carriers was consistently lower in older age groups and on average about 73% that of children <5 y among 5-17 y olds and adults respectively. We provide a prediction model to infer the carriage prevalence and serotype distribution in 5-17 y olds and adults as a function of that in children <5 years of age.

Conclusion: Such predictions are helpful for assessing the potential population-wide effects of vaccination programmes, e.g. via transmission models, and thus assist in the design of future pneumococcal conjugate vaccination strategies.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Figure 1
Figure 1. Flow chart of the study selection process.
Figure 2
Figure 2. Overall carriage prevalence in older age groups against <5 y olds: scatter plot and fitted model.
Each circle corresponds to one study, with the circle size proportional to the study size (i.e. number of individuals contributing to the x and y axis estimates). The lines correspond to the fitted Bayesian linear meta-regression model. The dashed black line shows the median posterior estimate and the grey shaded area the 95% credible interval around the median. The red dotted lines represent the 95% prediction interval.
Figure 3
Figure 3. VT proportion in carried serotypes among <5 y and older ages: scatter plot and fitted model.
Each circle corresponds to one study, with the circle size proportional to the study size (i.e. number of individuals contributing to the x and y axis estimates). The lines correspond to the fitted Bayesian linear meta-regression model. The dashed black line shows the median posterior estimate and the grey shaded area the 95% credible interval around the median. The red dotted lines represent the 95% prediction interval.
Figure 4
Figure 4. VT and NVT prevalence in 5–17 y olds against <5 y olds: scatter plot and fitted model.
Each circle corresponds to one study, with the circle size proportional to the study size (i.e. number of individuals contributing to the x and y axis estimates). The lines correspond to the fitted Bayesian linear meta-regression model. The dashed black line shows the median posterior estimate and the grey shaded area the 95% credible interval around the median. The red dotted lines represent the 95% prediction interval.
Figure 5
Figure 5. VT and NVT prevalence in adults against <5 y olds: scatter plot and fitted model.
Each circle corresponds to one study, with the circle size proportional to the study size (i.e. number of individuals contributing to the x and y axis estimates). The lines correspond to the fitted Bayesian linear meta-regression model. The dashed black line shows the median posterior estimate and the grey shaded area the 95% credible interval around the median. The red dotted lines represent the 95% prediction interval.

References

    1. Bogaert D, De Groot R, Hermans PW (2004) Streptococcus pneumoniae colonisation: the key to pneumococcal disease. Lancet Infect Dis 4: 144–154. - PubMed
    1. Halasa NB, Grijalva CG, Arbogast PG, Talbot TR, Craig AS, et al... (2013) Near Complete Elimination of the Seven Valent Pneumococcal Conjugate Vaccine Serotypes in Tennessee. Pediatr Infect Dis J. - PubMed
    1. Hammitt LL, Bruden DL, Butler JC, Baggett HC, Hurlburt DA, et al. (2006) Indirect effect of conjugate vaccine on adult carriage of Streptococcus pneumoniae: an explanation of trends in invasive pneumococcal disease. JInfectDis 193: 1487–1494. - PubMed
    1. Weinberger DM, Malley R, Lipsitch M (2011) Serotype replacement in disease after pneumococcal vaccination. Lancet 378: 1962–1973. - PMC - PubMed
    1. Fitzwater SP, Chandran A, Santosham M, Johnson HL (2012) The worldwide impact of the seven-valent pneumococcal conjugate vaccine. Pediatr Infect Dis J 31: 501–508. - PubMed

Publication types

MeSH terms